Literature DB >> 17255213

Frequency-dependent contractile strength in mice over- and underexpressing the sarco(endo)plasmic reticulum calcium-ATPase.

Nitisha Hiranandani1, Sripriya Raman, Anuradha Kalyanasundaram, Muthu Periasamy, Paul M L Janssen.   

Abstract

One of the prominent markers of end-stage heart failure at the molecular level is a decrease in function and/or expression of the sarcoplasmic reticulum ATPase protein [sarco(endo)plasmic reticulum calcium-ATPase, SERCA]. It has been often postulated that a decrease in SERCA pump activity can contribute in a major way to decreased cardiac function. To establish a functional relationship, we assessed how alterations in SERCA activity level affect basic contractile function in healthy myocardium devoid of other significant molecular changes. We investigated baseline contractile function, frequency-dependent activation, and beta-adrenergic response in ultrathin trabeculae isolated from hearts of mice overexpressing SERCA (transgenic, TG), underexpressing SERCA2a (heterozygous knockout, Het), and their respective wild-type (WT) littermates. At physiological temperature and frequency, compared with their respective WT littermates, SERCA1a mice displayed increased developed force at frequencies of 4-8 Hz ( approximately 90% increase at 4 Hz) and force equal to WT mice at 10-14 Hz. Force development at 4 Hz in presence of 1 muM isoproterenol was similar in TG and WT mice. In Het mice, developed force was nearly identical at the lower end of the frequency range (4-8 Hz) but slightly depressed at higher frequency (P < 0.05 at 14 Hz). In presence of 1 muM isoproterenol, developed force at 4 Hz was equal to that in WT mice. Compared with normal levels, increased SERCA activity enhanced force development only at subphysiological frequencies. A reduction in SERCA activity only showed a depression of force at the higher frequency range. Thus generalizations regarding the correlation between SERCA activity and contractility can be highly ambiguous, because this relationship is critically dependent on other factors including stimulation frequency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255213     DOI: 10.1152/ajpregu.00508.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

Review 1.  Myocardial contraction-relaxation coupling.

Authors:  Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

Review 2.  Determinants of frequency-dependent contraction and relaxation of mammalian myocardium.

Authors:  Paul M L Janssen; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2007-08-28       Impact factor: 5.000

3.  Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy.

Authors:  Ying Xu; Dawn A Delfín; Jill A Rafael-Fortney; Paul M L Janssen
Journal:  J Appl Physiol (1985)       Date:  2010-12-02

4.  Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere.

Authors:  Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-23       Impact factor: 4.733

5.  Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.

Authors:  J Michael O'Donnell; Aaron Fields; Xianyao Xu; Shamim A K Chowdhury; David L Geenen; Jian Bi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

6.  Contraction-relaxation coupling is unaltered by exercise training and infarction in isolated canine myocardium.

Authors:  Farbod Fazlollahi; Jorge J Santini Gonzalez; Steven J Repas; Benjamin D Canan; George E Billman; Paul M L Janssen
Journal:  J Gen Physiol       Date:  2021-07-05       Impact factor: 4.086

7.  Prominent heart organ-level performance deficits in a genetic model of targeted severe and progressive SERCA2 deficiency.

Authors:  Frazer I Heinis; Kristin B Andersson; Geir Christensen; Joseph M Metzger
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.